Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lilly to Announce Initial 2022 Financial Guidance; Provide R&D Overview at Investment Community Meeting

12/01/2021 | 10:01am EST

INDIANAPOLIS, Dec. 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will host a meeting for the investment community on Wednesday, Dec. 15, 2021, from 9 a.m. to 4 p.m., Eastern time.

Earlier that day, the company will announce its initial financial guidance for 2022, and at the meeting, Lilly leadership will further detail the 2022 financial guidance. A substantial portion of the meeting will cover Lilly's research and development opportunities, with a focus on the early-phase pipeline, in the areas of diabetes, immunology, neuroscience and oncology.

In-person attendance is by invitation only and advance registration is required. Investors, media and the general public can access a live video webcast through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on the website following the meeting.

About Eli Lilly and Company  
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY

Refer to:     

 Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)


 Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)     

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-announce-initial-2022-financial-guidance-provide-rd-overview-at-investment-community-meeting-301434679.html

SOURCE Eli Lilly and Company


ę PRNewswire 2021
All news about ELI LILLY AND COMPANY
01/18Evotec, Eli Lilly to Collaborate on Treatments for Metabolic Diseases
MT
01/18Evotec, Eli Lilly to Address Kidney Diseases, Diabetes in Three-Year Drug Discovery Col..
MT
01/18Eli Lilly, Evotec Team Up to Discover Drugs For Metabolic Diseases
MT
01/18Evotec SE Enters into a Drug Discovery Collaboration with Eli Lilly and Company
CI
01/17Abbisko Therapeutics Co., Ltd. Announces Worldwide Collaboration with Eli Lilly and Com..
CI
01/14Pieris Doses First Patient in Phase 2 Gastric Cancer Trial of Cinrebafusp Alfa
MT
01/14WHO recommendation on Merck's oral pill likely in early February
RE
01/13GSK-Vir, Eli Lilly's COVID-19 Treatments Recommended by WHO
MT
01/13WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool
RE
01/12Biogen shares slide as Medicare proposal restricts coverage of Alzheimer's treatments
RE
More news
Analyst Recommendations on ELI LILLY AND COMPANY
More recommendations